Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028675
Filing Date
2021-11-15
Accepted
2021-11-15 16:45:06
Documents
49
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1472984
2 ex10-39b.htm EX-10.39B 2888
3 ex31.htm EX-31 19595
4 ex32.htm EX-32 6851
5 ex10-39b_001.jpg GRAPHIC 255424
6 ex10-39b_002.jpg GRAPHIC 212475
7 ex10-39b_003.jpg GRAPHIC 197516
  Complete submission text file 0001493152-21-028675.txt   5880268

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clcs-20210930.xsd EX-101.SCH 36060
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clcs-20210930_cal.xml EX-101.CAL 43900
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clcs-20210930_def.xml EX-101.DEF 171367
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clcs-20210930_lab.xml EX-101.LAB 324203
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clcs-20210930_pre.xml EX-101.PRE 242112
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 570251
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 211411765
SIC: 2834 Pharmaceutical Preparations